Figure 4From: Temporal control of gene deletion in sensory ganglia using a tamoxifen-inducible Advillin-Cre-ERT2 recombinase mouse Tamoxifen induces Cre-expression during embryonic development. A - E18.5 AvCreERT2-positive embryos from tamoxifen treated pregnant females (2 mg per day, 5 days). B - E18.5 AvCreERT2-positive embryos from vehicle treated pregnant females.Back to article page